Thu, May 28|
How COVID-19 Pandemic is Accelerating Modern Medicine
Powered By Retrophin | Presented by LSIG (Life Sciences Special Interest Group)
Time & Location
May 28, 2020, 11:00 AM – 12:00 PM
About the Event
As businesses, patients, healthcare providers and government find a collective way forward in a post-COVID world, we’re all witnessing an accelerated transformation of modern healthcare.
This esteemed panel of public and private industry experts will uncover new avenues for health access with the surge of telemedicine adoption -as providers see more patients remotely to mitigate the risk of transmission- from the design of mobile testing technologies now deployed to expand point of care testing options to the FDA’s approach to bringing coronavirus prevention and treatments to market as fast as possible. It's clear that the dynamic nature of this black swan event demands a comprehensive and collaborative market response.
This program will provide critical insights and market perspectives to help us navigate this rapid industry growth while shining a light on the innovative hopes that reflect the fact that we’re in this together and we’ll get through this together.
Opening Remarks: Eric Dube, PhD | President & CEO, Retrophin
Ann Mond Johnson | CEO, American Telemedicine Association
Marsha Henderson | Former FDA Associate Commissioner
Katherine Atkinson | Chief Commercial Officer Truvian
Moderator | Dr. Anita Gupta | SVP Medical Strategy, Heron Therapeutics